Care
The medical device company has signed an MoU with DHI 2048 to deploy 2,500 systems to the region by the year 2025.
Also: NeuroFlow teams up with the Independence Blue Cross Foundation and Trinity Health Mid-Atlantic to provide its mental health software to frontline healthcare workers.
The new effort will focus on cardiometabolic conditions in order to give clinicians more insights into patient care.
The company says it will begin full commercial deployment of iSTRYM in the first quarter of 2022.
The company's chief product officer wrote that deleting content as quickly as possible doesn't fix the problem.
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The proposed system uses brain signals and neural patterns from children.
The small study found nearly all patients had a complete abortion without the need for intervention.
Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.
The Charge 5 is available today for preorder and will launch with worldwide availability in the fall.